NCT06709573View on ClinicalTrials.gov

Early Versus Late Adjunctive Vasopressin in Septic Shock

PHASE4RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 29, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 31, 2025

Conditions
SepsisSeptic Shock
Interventions
DRUG

vasopressin - early initiation

BPA fires to provider prompting vasopressin initiation when the norepinephrine dose is between 10-20 mcg/min

DRUG

vasopressin - standard initiation

BPA fires to provider prompting vasopressin initiation when the norepinephrine dose is between 20-35 mcg/min

Trial Locations (1)

44095

RECRUITING

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT06709573 - Early Versus Late Adjunctive Vasopressin in Septic Shock | Biotech Hunter | Biotech Hunter